đź“Š Evidence-Based Reference
sunsoft methafilocn a hydrophilic contact lens
Coopervision
Summary: The Sunsoft Methafilcon A is a hydrophilic contact lens primarily used for vision correction. It has been evaluated in clinical studies for its performance in presbyopia correction. Key evidence highlights its effectiveness in improving vision quality.
FDA Clearance Information
Pathway
PMA
Number
P850077 ↗
Decision Date
February 18, 1992
Product Code
LPL
Device Class
Class 2
Evidence
419 studies
The Sunsoft Methafilcon A contact lens was cleared by the FDA through the PMA pathway on February 18, 1992. It is manufactured by Coopervision and classified as a Class 2 medical device.
What It Is
The Sunsoft Methafilcon A is a hydrophilic contact lens designed for vision correction, particularly in presbyopic patients. It functions by providing multifocal vision correction through its unique lens design.
Clinical Applications
Commonly used in patients requiring multifocal vision correction, the Sunsoft Methafilcon A lens is suitable for those with presbyopia. It is often considered in scenarios where patients seek an alternative to spectacles.
Evidence Summary
The available literature includes a prospective clinical study and a comparative study, with publication years ranging from 1995 to 1996. These studies provide insights into the lens's performance and user satisfaction.
Reported Outcomes
Published studies report that the Sunsoft Methafilcon A lens effectively improves vision quality in presbyopic patients. The prospective study highlighted subjective factors influencing the purchase decision, indicating user satisfaction with the lens's performance.
Safety Profile
Reported complications include no specific adverse events or safety concerns documented in the provided studies. The evidence suggests a favorable safety profile, although detailed safety data is limited.
Evidence Limitations
The evidence is limited to two studies with small sample sizes, and there is a lack of recent data. Further research is needed to explore long-term safety and efficacy, as well as comparisons with other multifocal lenses.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Sunsoft Methafilcon A?
The Sunsoft Methafilcon A is indicated for vision correction in presbyopic patients, providing multifocal vision through its lens design.
What outcomes have been reported in clinical studies?
Clinical studies have reported improved vision quality and user satisfaction with the Sunsoft Methafilcon A lens for presbyopia correction.
What complications have been reported?
No specific complications or adverse events were reported in the provided studies, indicating a favorable safety profile.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.